Intravesical bacillus Calmette-Guerin combined with electromotive mitomycin for high-risk superficial bladder cancer

被引：3
作者：
Bochner, Bernard H. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Urol, Kimmel Ctr Prostate & Urol Canc, New York, NY 10021 USA
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2006年 / 3卷 / 09期
关键词：
bacillus Calmette-Guerin; bladder cancer; immunotherapy; intravesical; mitomycin;
D O I：
10.1038/ncponc0588
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：474 / 475
页数：2
相关论文
共 8 条
[1]   The treated natural history of high risk superficial bladder cancer: 15-year outcome [J].
Cookson, MS ;
Herr, HW ;
Zhang, ZF ;
Soloway, S ;
Sogani, PC ;
Fair, WR .
JOURNAL OF UROLOGY, 1997, 158 (01) :62-67
[2]   Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial [J].
Di Stasi, SM ;
Giannantoni, A ;
Giurioli, A ;
Valenti, M ;
Zampa, G ;
Storti, L ;
Attisani, F ;
De Carolis, A ;
Capelli, G ;
Vespasiani, G ;
Stephen, RL .
LANCET ONCOLOGY, 2006, 7 (01) :43-51
[3]  
HOLMANG S, 1995, J UROLOGY, V153, P18
[4]   Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study [J].
Lamm, DL ;
Blumenstein, BA ;
Crissman, JD ;
Montie, JE ;
Gottesman, JE ;
Lowe, BA ;
Sarosdy, MF ;
Bohl, RD ;
Grossman, HB ;
Beck, TM ;
Leimert, JT ;
Crawford, ED .
JOURNAL OF UROLOGY, 2000, 163 (04) :1124-1129
[5]   The role of a second transurethral resection for high-grade bladder cancer [J].
Langenstroer P. ;
See W. .
Current Urology Reports, 2000, 1 (3) :204-207
[6]   A randomized prospective study comparing long-term intravesical instillations of mitomycin C and Bacillus Calmette-Guerin in patients with superficial bladder carcinoma [J].
Lundholm, C ;
Norlen, BJ ;
Ekman, P ;
Jahnson, S ;
Lagerkvist, M ;
Lindeborg, T ;
Olsson, JO ;
Tveter, K ;
Wijkstrom, H ;
Westberg, R ;
Malmstrom, PU .
JOURNAL OF UROLOGY, 1996, 156 (02) :372-376
[7]  
PANSADORO V, 2006, TXB BLADDER CANC, P387
[8]   Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials [J].
Sylvester, RJ ;
van der Meijden, APM ;
Oosterlinck, W ;
Witjes, JA ;
Bouffioux, C ;
Denis, L ;
Newling, DWW ;
Kurth, K .
EUROPEAN UROLOGY, 2006, 49 (03) :466-477
1